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This exploratory trial evaluates the effect of a structured exercise (STEX) or life-
style intervention (PASS) program upon cardiovascular (CV) disease risk factors 
in children. Sixty-one schoolchildren were randomly assigned by school to an 
intervention or control (CON) condition. The effect of the STEX (compared with 
CON) was a mean benefit of −0.018 mm for average maximum carotid intima-
media thickness. The PASS intervention did not result in clinically important 
effects, and no other substantial changes were observed. Relatively high probability 
of clinically beneficial effects of the STEX intervention suggests that a larger, 
definitive randomized trial with longer follow-up is warranted.
A substantial body of scientific work promotes the importance of an active life-
style in the prevention of CV diseases (12,22). This literature has recently extended 
to the role of physical activity in the amelioration of risk factors for CV disease in 
children (16,18,21). Such interest has been prompted, partially, because of reports 
of increasing levels of childhood obesity and physical inactivity (19,24,35).
Signs and symptoms of clinical CV disease are rarely evident in children. Early 
(preclinical) noninvasive indicators of CV disease such as an elevation of carotid 
intima media thickness (IMT), an increased left ventricular (LV) mass, or a decrease 
in diastolic function have been used in recent research with children (9,14,23,32,34), 
however. Of further relevance to such risk factors is the fact that increased physical 
activity can have a positive impact upon carotid IMT (39), abnormal LV mass (1), 
*The current study was defined as an exploratory randomized trial, in accordance with the phased 
approach to the development and evaluation of interventions to improve health proposed by Campbell 
et al. (2000).
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and diastolic function (25,27). Because of the rarity of clinical vascular events in 
the young, carotid IMT might be especially relevant as a primary outcome variable 
for epidemiological and treatment studies in young population samples (20).
Physical activity interventions to reduce CV disease risk in children have 
tended to involve traditional structured exercise prescription (1,25,27,39), and 
less attention has been paid to the integration of physical activity into daily life 
through less-structured sports-specific exercise programs (13). Various theories and 
models to understand and change lifestyle behavior have been proposed (3) and 
some recent interventions based on behavior change theories have been studied 
in an attempt to decrease sedentary behavior in children (30). The comparison of 
structured exercise interventions with lifestyle programs upon CV risk factors in 
children has rarely been attempted.
The purpose of this study was, therefore, to assess the impact of a traditional 
exercise prescription and a lifestyle intervention program upon early prognostic risk 
factors for CV disease in primary school children. Both groups were compared with 
a control group who received no formal physical activity intervention. The current 
study was defined as an exploratory randomized trial (Phase II), in accordance with 
the phased approach to the development and evaluation of interventions to improve 
health proposed by Campbell et al. (6).
Methods
Participants
After local ethical approval, schools within Merseyside were recruited via direct 
contact. Eight schools were selected based on school size (large), availability of 
school sports facilities (accessible), current afterschool club provision (limited), and 
socioeconomic status of the area (deprived). Three schools volunteered to participate. 
After fully informed agreement from head teachers all year, 6 children age 10–11 
years (n = 180) were informed about the project and asked to return signed parental 
consent and medical forms. Exclusion criteria included current use of prescription 
medication, any personal history of asthma or respiratory problems, heart, or vascular 
complaints as well as an early family history of sudden death. Sixty-one children 
(36 female and 25 male) 10–11 (11.0 ± 0.3) years of age met these criteria, provided 
written and parental consent, and went on to complete the study.
Design
Schools were randomly assigned to one of three groups to mitigate potential 
contamination effects across arms of the trial. The three groups were a structured 
high-intensity exercise program (STEX), a lifestyle intervention group in a physical 
activity signposting scheme (PASS); or a control (CON) group. All laboratory data 
were collected at baseline and after 9 weeks (post intervention).
Physical Activity Signposting Scheme (PASS)
Social cognitive theory (2) and ecological theory (29) were the basis for the PASS 
intervention. Nine weekly missions or tasks were sent by post to each child. 
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Missions were derived using an intervention mapping approach to try to link the 
theories specifically to each task with the aim to increase habitual physical activity 
and decrease sedentary behavior (e.g., to promote active transport and reduce TV 
viewing). In accordance with the social cognitive theory, children were informed 
of the benefits of being active including the enhancement of confidence and skill 
level. Different environmental contexts were used including the home and local 
neighborhood. In line with the ecological theory, this aimed to help them understand 
their surroundings and how to become active in it on their own, as well as with 
family and friends. Pedometers were used as a physical activity promotion tool in 
conjunction with the missions. Examples of some of the tasks included a “switch 
off TV challenge” after 2 hr of viewing a day, increasing activity by monitoring 
active transport, for example, getting off the bus a stop earlier, and taking part in 
a new activity at least once a week with your family. Ninety-two percent of the 
children returned the mission in week one and all met the compliance criterion of 
a 75% return rate for the duration of the study.
Structured High-Intensity Exercise Program (STEX)
Children attended twice-weekly hour-long afterschool exercise sessions for 9 
weeks. These consisted of multiactivities such as circuits, dance, and games. 
The aim of the session was to perform whole body muscular activity which was 
nonsports-specific and to maintain heart rate above 70% of maximum heart rate 
(145 beats.min–1). This was verified by intermittent heart rate monitoring (Polar 
Electro, Kempele, Finland). All children met the criteria for attendance of at least 
75% of STEX sessions.
Control (CON)
The CON group was asked to maintain their normal activity levels. They received 
the same prestudy information packs as the other two groups, however no further 
physical activity information was given.
Ultrasound Measurements
A single trained ultrasound technician performed all ultrasound measurements. 
Two-dimensional, M-mode, Doppler, and tissue Doppler imaging (TDI) echocar-
diographic scans were performed using a standard ultrasound system (Mylab30CV 
system, ESAOTE, Italy) with a 2.5 MHz phased array transducer. All participants 
where assessed in the left lateral decubitus position.
Carotid Intima-Media Thickness (IMT)
Ten millimeter segments of the far wall of the common carotid artery (CCA) 1–2 
cm proximal to the carotid bulb were imaged with a 10–15 MHz linear transducer. 
Four images were taken bilaterally and analyzed off-line (IMT.LABORATORY 
version 1.1, Pie Medical Equipment, The Netherlands). This software provides 
average mean and maximum values for carotid IMT via tracking the interfaces of 
the lumen-intima and media adventitia.
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Cardiac Structure
Left ventricular structures and LV mass were assessed using parasternal long axis 
images and M-mode scans at the level of the mitral valve. Wall thickness and cavity 
dimensions were measured according to the American Society of Echocardiography 
(31). Left ventricular mass was calculated according to a validated, regression-
corrected formula (11). To determine a size-independent LV mass index, LV mass 
was divided by height2.7.(10).
Diastolic Function
From the apical four-chamber view Doppler recordings were taken of mitral inflow 
by placing a 2 mm sample volume at the tips of the mitral leaflets and parallel with 
flow. Peak early (E) and late/atrial (A) flow velocities were obtained and E/A ratio 
reported. In the same view pulsed TDI velocities were obtained from the septal 
annular site using a 2 mm sample volume. Peak early diastolic (E') and late diastolic 
(A') myocardial tissue velocities were recorded and E'/A' ratio was derived. The 
intraobserver coefficient of variance for LVM, E'/A' ratio and cIMT was reported 
as 7.4%, 11.5% and 1.2% respectively.
Other Outcome Measures
Standard anthropometrics including body mass (Seca Limited, Birmingham UK), 
stature (Leister height measure, Birmingham, UK), and body mass index (weight 
[kg]/height [m]2) were recorded. Body composition was assessed using dual-energy 
X-ray absorptiometry (DEXA; Lunar Hologic QDR, USA) in which the whole 
body was scanned. Key variables assessed were lean body mass (kg), fat mass 
(kg), and percent body fat. After 5 min of supine-seated rest, brachial artery blood 
pressures and heart rate (Bosch and Sohn, Germany) were assessed twice with the 
lowest score noted.
Statistical Analysis
Values are presented as mean ± SD. The carotid IMT was defined a priori as the 
primary outcome variable, with the other measured variables classed as secondary 
outcomes. Analysis of covariance was conducted to evaluate the effectiveness of the 
9-week interventions. The independent variable was the type of intervention (STEX 
or PASS vs. CON), with the dependent variable as the change score (post minus 
baseline). The baseline score served as the covariate to control for chance imbal-
ances across groups at baseline (38). Exploratory analyses indicated no substantial 
interactions with gender; therefore, boys and girls were merged into a single group 
for the primary analysis. An estimation approach was considered superior to a null 
hypothesis testing framework (8), presenting the mean effects of each intervention 
(versus control) on the primary outcome, together with 90% confidence intervals as 
suggested by Sterne and Smith (37). In line with the recommendations of Perneger 
(28), Bonferroni corrections of confidence intervals were not applied.
Adjusted mean intervention effects were evaluated for their clinical signifi-
cance by prespecifying the minimum clinically importance difference (MCID; 4). 
In the absence of a robust clinical anchor, the MCID is defined conventionally 
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using a distribution-based method as a Cohen’s d (difference in the change scores 
between groups) of 0.2 between subject standard deviations (7). The SD of the 
pooled baseline scores was used for this purpose, because the posttest SD might 
be inflated by individual differences in responses to the intervention. The MCID 
was interpreted as “benefit” or “harm” according to the direction of the effect on 
the intervention for a given variable. As a Phase II exploratory trial, the current 
study is not powered to precisely define changes as small as the MCID. The effects 
observed, however, will provide important information to inform sample-size 
estimations in any subsequent Phase III trial (6).
Using the mean intervention effect together with its uncertainty, the probability 
(percent chances) that the true population effect was as least as large as the MCID 
was calculated (4,15,33). Briefly, this process requires the calculation of a t statistic 
for the intervention effect. The conventional t statistic involves a test against the 
null hypothesis of zero effect (t = (mean difference between groups−zero)/ standard 
error of the difference). To calculate the probability of clinical benefit, the zero in 
this formula is replaced by the prespecified value for the MCID: t = (mean differ-
ence between groups−MCID)/ standard error of the difference. With the correct 
degrees of freedom for the comparison, the area under the t distribution curve to 
the left of the t value returns the probability that the true population effect of the 
intervention is at least as large as the MCID. All analyses were carried out on SPSS 
statistical package 14.0 (SPSS Inc., Chicago, USA).
Results
Data for age, body size and composition is presented in Table 1. Between-group 
differences in variables at baseline were not substantial although there was a trend 
for a greater BMI, waist circumference, fat mass and percent body fat in the control 
group. After the 9-week intervention there were no clinically substantial differences 
in  scores between groups for all body size variables.
Data from cardiovascular primary and secondary outcomes are presented in 
Table 2. There were no clinically substantial intervention effects for any second-
ary variable. Figure 1 and 2 demonstrate the mean  scores (adjusted for baseline 
imbalance) for average mean and average maximum cIMT, respectively. The 
minimum clinically important difference (MCID), defined as 0.2 between-subject 
standard deviations, was 0.008 mm for both average mean cIMT and average 
maximum cIMT. The effect of the STEX intervention (compared with CON) was 
a mean benefit of –0.018 mm for average maximum cIMT (90% CI, –0.039–0.002 
mm), and –0.016 mm for average mean cIMT (90% CI, –0.040–0.008 mm). The 
probability (% chances) that the effect of the STEX intervention was at least the 
MCID was 79% for average maximum and 71% for average mean carotid IMT. 
The PASS intervention did not result in clinically important effects.
Discussion
To the authors’ knowledge, this is the first exploratory trial to assess the impact of 
both a structured exercise program, as well as a lifestyle intervention upon early 
risk factors for CV disease in children. Whereas most body composition and CV 
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risk factor variables did not change meaningfully, an interesting and potentially 
clinically relevant change in cIMT was observed in the STEX group compared 
with CON. On this basis, cIMT might be a more sensitive variable than traditional 
risk factors and other variables assessed within the current study to track changes 
in CV risk due to physical activity interventions (5).
Table 1 Anthropometrics Data in All Groups Pre- and 
Postintervention
CON (n = 30) PASS (n = 15) STEX (n = 16)
Mean 
Value SD
Mean 
Value SD
Mean 
Value SD
Age (yr)
Baseline 11.0 (0.3) 11.0 (0.3) 11.1 (0.3)
Posttest 11.2 (0.3) 11.2 (0.4) 11.3 (0.3)
 0.2 (0.3) 0.2 (0.3) 0.2 (0.3)
Body mass (kg)
Baseline 40.7 (7.6) 40.7 (8.9) 41.4 (10.7)
Posttest 44.8 (9.4) 42.4 (9.6) 42.9 (11.1)
 4.1 (7.4) 1.7 (8.4) 1.5 (10.6)
Stature (m)
Baseline 1.48 (0.09) 1.44 (0.07) 1.48 (0.07)
Posttest 1.49 (0.09) 1.46 (0.07) 1.50 (0.07)
 0.01 (0.09) 0.02 (0.07) 0.02 (0.07)
BMI (kg/m2)
Baseline 19.8 (3.1) 19.3 (3.0) 18.7 (3.3)
Posttest 20.0 (3.1) 19.7 (3.3) 18.8 (3.3)
 0.2 (0.5) 0.4 (0.5) 0.1 (0.3)
Waist circumference 
(cm)
Baseline 69.6 (9.6) 68.0 (10.0) 65.6 (10.9)
Posttest 70.9 (10.8) 68.5 (9.5) 64.9 (10.9)
 1.3 (4.7) 0.5 (2.7) −0.7 (−2.7)
Fat mass (g)
Baseline 12018 (5240) 10618 (4547) 11452 (6324)
Posttest 12667 (5431) 11394 (4831) 11819 (6687)
 649 (966) 776 (904) 368 (563)
Lean mass (g)
Baseline 30383 (5047) 29234 (5168) 29060 (4886)
Posttest 31265 (5136) 30226 (5628) 30307 (4995)
 882 (845) 992 (826) 1246 (796)
% Fat mass (%)
Baseline 26.7 (7.4) 25.1 (5.8) 26.2 (7.3)
Posttest 27.1 (7.1) 25.7 (5.9) 26.0 (7.6)
 0.4 (7.3) 0.6 (5.8) −0.2 (7.6)
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Table 2 Cardiovascular Data in All Groups Pre- and 
Postintervention
Control group  
(n = 30)
PASS  
(n = 15)
STEX  
(n = 16)
Mean 
Value SD
Mean 
Value SD
Mean 
Value SD
Systolic BP (mmHg)
Baseline 126 (26) 130 (34) 113 (24)
Posttest 134 (30) 137 (41) 123 (39)
 8 (21) 7 (23) 10 (23)
Diastolic BP (mmHg)
Baseline 67 (7) 68 (8) 68 (4)
Posttest 62 (5) 61 (7) 62 (5)
 −5 (6) −7 (8) −6 (6)
Resting heart rate 
(bpm)
Baseline 73 (10) 75 (9) 74 (11)
Posttest 70 (9) 73 (10) 71 (8)
 −3 (9) −2 (9) −3 (9)
LV mass (g)
Baseline 126 (26) 130 (34) 113 (24)
Posttest 134 (30) 137 (41) 123 (39)
 8 (21) 7 (23) 10 (23)
LV mass indexed (g/
m2)
Baseline 42.1 (10.5) 47.6 (9.6) 39.8 (6.8)
Posttest 45.0 (7.0) 48.8 (12.4) 40.2 (7.9)
 2.8 (10.7) 1.2 (8.1) 2.4 (7.9)
E/A ratio (m/s)
Baseline 2.12 (0.52) 1.98 (0.45) 2.04 (0.47)
Posttest 2.05 (0.50) 1.87 (0.41) 2.01 (0.55)
 −0.07 (0.42) −0.11 (0.31) −0.03 (0.51)
E'/A' ratio (cm/s)
Baseline 2.65 (0.70) 2.24 (0.57) 2.58 (0.67)
Posttest 2.85 (0.60) 2.36 (0.50) 2.62 (0.67)
 0.20 (0.64) 0.12 (0.53) 0.04 (0.51)
Average mean cIMT 
(mm)
Baseline 0.389 (0.043) 0.409 (0.032) 0.423 (0.039)
Posttest 0.400 (0.045) 0.405 (0.067) 0.402 (0.029)
 0.011 (0.039) −0.004 (0.061) −0.021 (0.047)
Average max cIMT 
(mm)
Baseline 0.405 (0.041) 0.425 (0.031) 0.440 (0.040)
Posttest 0.419 (0.046) 0.437 (0.053) 0.423 (0.026)
 0.014 (0.035) 0.011 (0.045) −0.017 (0.043)
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The current data partially supports previous research (36,39) that reported 
decreased cIMT with exercise training and extends this data to suggest that even 
short-term interventions may produce favorable responses in cIMT. Research 
with adults has proposed that an increase in cIMT of just 0.034 mm a year is an 
independent risk factor for CV disease (17). Similarly, a 1 SD increase in cIMT 
was associated with a twofold increased risk of ischemic stroke or myocardial 
infarction (26). Such data are unavailable for the age range in the current study, 
so the MCID was defined as 0.2 between-subject standard deviations—a reduc-
tion in cIMT of 0.008 mm. The calculated probability that the effect of the STEX 
intervention exceeded this threshold (defining clinical benefit for reduction in 
cIMT) was relatively high (0.71–0.79). For average maximum cIMT, the calculated 
probability reflected odds of approximately 4:1 in favor of the STEX intervention 
being clinically beneficial, with odds of greater than 2:1 that the intervention was 
beneficial for average mean cIMT.
Figure 2 — ∆ scores for adjusted average maximum carotid IMT over the 9-week inter-
vention period in all groups.
Figure 1 — ∆ scores for adjusted average mean carotid IMT over the 9-week intervention 
period in all groups.
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Clearly, other researchers and clinicians might disagree with the value speci-
fied in the current study for the MCID. For those desiring a different threshold to 
define the MCID, an example of a clinical significance curve, as recommended by 
Shakespeare et al. (33), is presented in Figure 3. In the current study, prespecify-
ing a larger MCID of half a standard deviation (0.02 mm) for average maximum 
cIMT, for example, results in a probability of clinical benefit of 0.44 (indicating 
that the intervention would be about as likely to be clinically worthwhile as not). 
Half a standard deviation, however, represents a moderate effect size, and it is 
believed that even small changes of carotid IMT might be clinically relevant at a 
population level (39). Certainly, the findings provide sufficiently robust evidence of 
STEX benefit to warrant further investigation in a definitive randomized controlled 
trial. The PASS group did not produce such positive results for average mean and 
maximum cIMT. This is likely to be a result of a reduced intensity, duration and 
thus volume of physical activity in PASS compared with STEX.
Changes in other CV risk variables were not substantially different between 
groups. This likely reflects the short nature of the intervention or the relative health 
of the heterogeneous primary school population. A longer intervention may be 
warranted to assess the impact of STEX and PASS on LV mass and diastolic func-
tion possibly in more “at risk” children. The lack of change in diastolic functional 
variables is somewhat at odds with past research (25,27) but is likely because these 
data were derived from cross-sectional comparisons of trained and untrained chil-
dren, which represents a greater exercise stimulus accumulated over many years. 
Moreover, it is almost axiomatic that cross-sectional effects are larger than those 
observed in experimental designs.
As with CV risk factors, there were no substantial between group differences in 
 scores for body size and composition variables. Of some interest, however, was a 
small decrease in waist circumference and percentage fat mass in the STEX group 
compared with a small increase in the CON and PASS groups. Such group differ-
ences would be interesting to explore further in a more prolonged intervention.
Figure 3 — The probability that the true population intervention effect exceeds a chosen 
Minimum Clinically Important Difference (MCID; change in average maximum carotid 
IMT).
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Of potential interest to future research was the relative success of the imple-
mentation of both the PASS and STEX interventions in primary schoolchildren. As 
an exploratory trial, it was positive to observe participants attain a 75% criterion for 
attendance or completion of signposting tasks. In addition, a poststudy review of 
attendance and return, logistics of delivery, and logistics of testing and assessment 
were all positive. Positive feedback was also given from questionnaires completed 
by participants and parents. It is, though, pertinent to note some lessons for future 
studies. In the PASS scheme, response rates varied task to task and generally 
declined over the 9-week period. It is recommended that attention needs to be paid 
to nature of the tasks including an attempt to enhance the intensity of the program 
similar to that of the STEX group. Implementation of positive reinforcement such 
as a reward scheme could be introduced, as well as structured support from the 
child’s school and family is also important to help maintain adherence. In addi-
tion, data related to habitual physical activity levels would be useful and provide 
extra insight into the effectiveness of the specific interventions. Physical activity 
data collection was attempted in this exploratory trial, but logistical and technical 
problems prevented these data being included in the analyses.
On the basis of the current findings and the lessons learned from this exploratory 
study, we propose the implementation of a reward scheme to reinforce positive 
behavior change in addition to a longer intervention period with a larger sample 
size in a definitive (Phase III) randomized controlled trial (6). A larger trial would 
enable the potential clinical benefit of the intervention to be estimated more pre-
cisely. The targeting of children with higher risk of cardiovascular disease would 
also be valuable (e.g., overweight and obese). In addition, in future research the 
impact that the STEX and PASS interventions have on habitual physical activity 
and associated energy expenditure should be considered.
In conclusion, this exploratory trial of a STEX and PASS intervention in pri-
mary schoolchildren showed the interventions to be feasible, whereas the STEX 
intervention produced small but potentially clinically beneficial changes in the 
cIMT primary outcome variable. The focus of the current study on quantifying 
the probability for the potential benefit of the intervention encourages researchers 
and clinicians to justify their choice of the smallest clinically worthwhile effect 
and enhances clinical decision-making (33). Future research might provide greater 
insight into changes in cIMT after exercise interventions in children but might wish 
to target longer training periods and more at risk cohorts.
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